| II-078 Simon Koele Population pharmacokinetics and exposure-response of BTZ-043 for the treatment of tuberculosis. Wednesday 15:20-16:50 |
| II-079 Simon Koele Model-informed trial design for the malaria transmission blocking antibody TB31F Wednesday 15:20-16:50 |
